Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Servier - Advancements in Metastatic Pancreatic Cancer: Which perspectives for patients?

Panel discussion

Date

13 Sep 2024

Session

Servier - Advancements in Metastatic Pancreatic Cancer: Which perspectives for patients?

Topics

Tumour Site

Pancreatic Adenocarcinoma

Presenters

Eric Van Cutsem, Teresa Macarulla Mercade, Gerald Prager, Jean-Luc van Laethem, Masafumi Ikeda

Authors

E. Van Cutsem1, T. Macarulla Mercade2, G. Prager3, J. van Laethem4, M. Ikeda5

Author affiliations

  • 1 Digestive Oncology Department, UZ Leuven - University Hospitals Leuven - Campus Gasthuisberg, 3000 - Leuven/BE
  • 2 Medical Oncology Dept., Vall d'Hebron Institute of Oncology - Cellex Center, 8035 - Barcelona/ES
  • 3 Department Of Medicine I, Universitätskliniken der MedUni Wien - AKH Wien, 1090 - Vienna/AT
  • 4 Erasme University Hospital-(Universite Libre de Bruxelles), 1070 - Brussels/BE
  • 5 Hepatobiliary & Pancreatic Oncology Dept., National Cancer Center Hospital East, 277-8577 - Kashiwa/JP

Resources

This content is available to ESMO members and event participants.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.